Knockdown of APLP2 and APP were observed to reduce pancreatic cancer cell growth by more than 60%, and S2-013 cells treated with a β-secretase inhibitor prevented the formation of APLP2 C-terminal fragments and decreased growth [49]. The gene discussed is APP; the disease is pancreatic neoplasm.